Anthony T. Rice; Maxwell I. Martin; Molly C. Warndorf; Glenn P. A. Yap; and Joel Rosenthal
Abstract
Photodynamic therapy (PDT), which involves the photoinduced sensitization of singlet oxygen, is an attractive treatment for certain types of cancer. The development of new photochemotherapeutic agents remains an important area of research. Macrocyclic tetrapyrrole compounds including porphyrins, phthalocyanines, chlorins, and bacteriochlorins have been pursued as sensitizers of singlet oxygen for PDT applications but historically are difficult to prepare/purify and can also suffer from high nonspecific dark toxicity, poor solubility in biological media, and/or slow clearance from biological tissues. In response to these shortcomings, we have developed a series of novel linear tetrapyrrole architectures complexed to late transition metals as potential PDT agents. We find that these dimethylbiladiene (DMBil1) tetrapyrrole complexes can efficiently photosensitize generation of 1O2 oxygen upon irradiation with visible light. To extend the absorption profile of the DMBil1 platform, alkynyl–aryl groups have been conjugated to the periphery of the tetrapyrrole using Sonogashira methods. Derivatives of this type containing ancillary phenyl (DMBil–PE), naphthyl (DMBil–NE), and anthracenyl (DMBil–AE) groups have been prepared and characterized. In addition to structurally characterizing Pd[DMBil–NE] and Pd[DMBil–AE], we find that extension of the tetrapyrrole conjugation successfully red-shifts the absorption of the DMBil–Ar family of biladienes further into the phototherapeutic window (i.e., 600–900 nm). Photochemical sensitization studies demonstrate that our series of new palladium biladiene complexes (Pd[DMBil–Ar]) can sensitize the formation of 1O2 with quantum yields in the range ΦΔ = 0.59–0.73 upon irradiation with light of λ ≥ 650 nm. The improved absorption properties of the Pd[DMBil–Ar] complexes in the phototherapeutic window, together with their high 1O2 quantum yields, highlight the promise of these compounds as potential agents for PDT.